A generic formulation indicated for Autoimmune Care and Antiparasitics. Use assists in modulating immune system activity to dampen chronic inflammatory responses.
A DMARD utilized to manage symptoms of lupus and rheumatoid arthritis and intended to alleviate malarial infections to support long-term immune stability.
Mechanism of Action
For arthritis, it interferes with immune cell communication and reduces inflammation. For malaria, it raises the pH of the parasite's food vacuole, causing death.
Route of Administration
Oral
Onset Time
Weeks to months (autoimmune)
Duration
Very long half-life
Contraindications
Retinal or visual field changes, Allergy to chloroquines
Severe Adverse Events
Irreversible retinopathy (vision loss), Cardiomyopathy, Severe hypoglycemia, Blood disorders
Common Side Effects
Nausea, Stomach cramps, Loss of appetite
Uncommon Side Effects
Diarrhea, Skin rash, Headache, Dizziness
Drug Interactions
Digoxin, Insulin, Antacids, Tamoxifen, Amiodarone
Pregnancy Safety Warnings
Considered low risk for lupus/malaria but requires monitoring.
Information for Hydroxychloroquine is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
